- Home
- LAZR vs FDMT Comparison
LAZR vs FDMT Comparison
Compare LAZR & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZR
- FDMT
- Stock Information
- Founded
- LAZR 2012
- FDMT 2013
- Country
- LAZR United States
- FDMT United States
- Employees
- LAZR N/A
- FDMT N/A
- Industry
- LAZR Auto Parts:O.E.M.
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- LAZR Consumer Discretionary
- FDMT Health Care
- Exchange
- LAZR Nasdaq
- FDMT Nasdaq
- Market Cap
- LAZR 215.6M
- FDMT 192.2M
- IPO Year
- LAZR N/A
- FDMT 2020
- Fundamental
- Price
- LAZR $3.03
- FDMT $4.38
- Analyst Decision
- LAZR Hold
- FDMT Buy
- Analyst Count
- LAZR 7
- FDMT 10
- Target Price
- LAZR $37.83
- FDMT $32.33
- AVG Volume (30 Days)
- LAZR 3.1M
- FDMT 538.6K
- Earning Date
- LAZR 08-05-2025
- FDMT 08-07-2025
- Dividend Yield
- LAZR N/A
- FDMT N/A
- EPS Growth
- LAZR N/A
- FDMT N/A
- EPS
- LAZR N/A
- FDMT N/A
- Revenue
- LAZR $73,313,000.00
- FDMT $23,000.00
- Revenue This Year
- LAZR $16.38
- FDMT $13,048.65
- Revenue Next Year
- LAZR $30.37
- FDMT N/A
- P/E Ratio
- LAZR N/A
- FDMT N/A
- Revenue Growth
- LAZR N/A
- FDMT N/A
- 52 Week Low
- LAZR $2.52
- FDMT $2.24
- 52 Week High
- LAZR $32.70
- FDMT $28.93
- Technical
- Relative Strength Index (RSI)
- LAZR 45.89
- FDMT 55.56
- Support Level
- LAZR $2.73
- FDMT $3.68
- Resistance Level
- LAZR $3.05
- FDMT $4.40
- Average True Range (ATR)
- LAZR 0.17
- FDMT 0.27
- MACD
- LAZR 0.05
- FDMT -0.02
- Stochastic Oscillator
- LAZR 91.15
- FDMT 59.57
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and Advanced Technologies and Services. The majority of its revenue is generated from the Autonomy Solutions segment, which engages in the design, manufacturing, and sale of LiDAR sensors, catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries. The Advanced Technologies and Services segment provides semiconductors and related components, as well as design, test, and consulting services to the Autonomy Solutions segment and various third-party customers. Geographically, the company derives its key revenue from North America.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.